Literature DB >> 17334549

Digestive tract microbiota in healthy volunteers.

Bruno Zilberstein1, Alina G Quintanilha, Manoel A A Santos, Denis Pajecki, Eduardo G Moura, Paulo Roberto Arruda Alves, Fauze Maluf Filho, João Ary Ubriaco de Souza, Joaquim Gama-Rodrigues.   

Abstract

PURPOSE: The aim of this study was to standardize the methods of sample collection of mucus from the digestive tract and to determine the microbiota in healthy volunteers from Brazil, collecting samples from the mouth, esophagus, stomach, duodenum, jejunum, ileum, colon, and rectum.
METHODS: Microbiota of selected healthy volunteers from the oral cavity (n=10), the esophagus (n=10), the upper digestive tract (n=20), and the lower digestive tract (n=24) were evaluated through distinct collection methods. Collection methods took into account the different sites, using basic scraping and swabbing techniques, stimulated saliva from the oral cavity, irrigation-aspiration with sterile catheters especially designed for the esophagus, a probe especially designed for upper digestive tract, and a special catheter for the lower digestive tract.
RESULTS: (i) Mixed microbiota were identified in the oral cavity, predominantly Gram-positive aerobic and anaerobic cocci; (ii) transitional flora mainly in the esophagus; (iii) Veillonella sp, Lactobacillus sp, and Clostridium sp in the stomach and duodenum; (iv) in the jejunum and upper ileum, we observed Bacteroides sp, Proteus sp, and Staphylococcus sp, in addition to Veillonella sp; (v) in the colon, the presence of "nonpathogenic" anaerobic bacteria Veillonella sp (average 10(5) UFC) indicates the existence of a low oxidation-reduction potential environment, which suggests the possibility of adoption of these bacteria as biological markers of total digestive tract health.
CONCLUSIONS: The collection methods were efficient in obtaining adequate samples from each segment of the total digestive tract to reveal the normal microbiota. These procedures are safe and easily reproducible for microbiological studies.

Entities:  

Mesh:

Year:  2007        PMID: 17334549     DOI: 10.1590/s1807-59322007000100008

Source DB:  PubMed          Journal:  Clinics (Sao Paulo)        ISSN: 1807-5932            Impact factor:   2.365


  40 in total

1.  Gut microbial differences in breast and prostate cancer cases from two randomised controlled trials compared to matched cancer-free controls.

Authors:  K S Smith; A D Frugé; W van der Pol; N E Caston; C D Morrow; W Demark-Wahnefried; T L Carson
Journal:  Benef Microbes       Date:  2021-04-01       Impact factor: 4.205

Review 2.  The impact of proton pump inhibitors on the human gastrointestinal microbiome.

Authors:  Daniel E Freedberg; Benjamin Lebwohl; Julian A Abrams
Journal:  Clin Lab Med       Date:  2014-09-24       Impact factor: 1.935

3.  Evaluation of methods for H. pylori detection in PPI consumption using culture, rapid urease test and smear examination.

Authors:  Farideh Siavoshi; Parastoo Saniee; Saman Khalili-Samani; Farideh Hosseini; Fahimeh Malakutikhah; Marzieh Mamivand; Somayeh Shahreza; Amir Houshang Sharifi
Journal:  Ann Transl Med       Date:  2015-01

Review 4.  Proteus spp. as Putative Gastrointestinal Pathogens.

Authors:  Amy L Hamilton; Michael A Kamm; Siew C Ng; Mark Morrison
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

Review 5.  Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects.

Authors:  Denisse Bravo; Anilei Hoare; Cristopher Soto; Manuel A Valenzuela; Andrew Fg Quest
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

6.  Characterization of Gastric Microbiota in Twins.

Authors:  Quanjiang Dong; Yongning Xin; Lili Wang; Xinying Meng; Xinjuan Yu; Linlin Lu; Shiying Xuan
Journal:  Curr Microbiol       Date:  2016-12-12       Impact factor: 2.188

7.  In Vivo Analysis of the Viable Microbiota and Helicobacter pylori Transcriptome in Gastric Infection and Early Stages of Carcinogenesis.

Authors:  Kaisa Thorell; Johan Bengtsson-Palme; Oscar Hsin-Fu Liu; Reyna Victoria Palacios Gonzales; Intawat Nookaew; Linda Rabeneck; Lawrence Paszat; David Y Graham; Jens Nielsen; Samuel B Lundin; Åsa Sjöling
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

Review 8.  Participation of microbiota in the development of gastric cancer.

Authors:  Li-Li Wang; Xin-Juan Yu; Shu-Hui Zhan; Sheng-Jiao Jia; Zi-Bin Tian; Quan-Jiang Dong
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

9.  Comparative analysis of intestinal microbial community diversity between healthy and orally infected ducklings with Salmonella enteritidis by ERIC-PCR.

Authors:  Sheng-Yan Cao; Ming-Shu Wang; An-Chun Cheng; Xue-Feng Qi; Xiao-Yan Yang; Shu-Xuan Deng; Nian-Chun Yin; Zhen-Hua Zhang; Deng-Chun Zhou; De-Kang Zhu; Qi-Hui Luo; Xiao-Yue Chen
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

10.  Hydrogenase-3 contributes to anaerobic acid resistance of Escherichia coli.

Authors:  Ken Noguchi; Daniel P Riggins; Khalid C Eldahan; Ryan D Kitko; Joan L Slonczewski
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.